Christina Ornauer: Exploring the Latest Advances in Hematology at EHA 2026
Christina Ornauer, Vice President, Head of Medical Affairs of Hematology Europe at Avanzanite Bioscience, shared a post on LinkedIn:
“Attending EHA 2026 was truly inspiring, as I connected with dedicated colleagues, researchers, and healthcare professionals focused on advancing patient care.
The congress showcased the remarkable pace of innovation in hematology and emphasized the importance of collaboration within the healthcare community.
I am grateful for the opportunity to learn, exchange perspectives, and bring new insights back to my work.
Thank you to everyone who shared their expertise and passion throughout the meeting.
I look forward to seeing how these advances continue to shape the future for patients.”

Stay updated with Hemostasis Today.
-
Nov 17, 2026, 15:26Hereditary Hemorrhagic Telangiectasia: The Molecular Connection Between Vascular Malformations and Bleeding
-
Nov 17, 2026, 14:54Cindy Neunert: Beyond Platelet Counts – Addressing Fatigue and Whole-Person Care in ITP
-
Nov 17, 2026, 14:44Strengthening Haemophilia Diagnosis Through Hands-On Laboratory Training – IAHAD
-
Nov 17, 2026, 14:40Platelet Membrane Protrusions Beyond Their Role in Hemostasis – JTH
-
Nov 17, 2026, 14:10Wolfgang Miesbach: Aspirin vs Anticoagulants – Who Needs More Than Aspirin?
-
Nov 17, 2026, 14:08Chaza Alaji: Soluble Transferrin Receptor – A Key to Uncovering Hidden Iron Deficiency
-
Nov 17, 2026, 14:03Shadi Tabibian: Fibrinogen – From Molecular Structure to Clinical Decision Making
-
Nov 17, 2026, 13:54Gabrielle Sarlon: Breaking the Silence on Menstrual Bleeding During Anticoagulant Therapy
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome